Soluble CD163MØLLER, Holger J.Scandinavian journal of clinical & laboratory investigation. 2012, Vol 72, Num 1, pp 1-13, issn 0036-5513, 13 p.Article

Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapySANDRI, Maria Teresa; JOHANSSON, Harriet Ann; ZORZINO, Laura et al.Cancer. 2007, Vol 110, Num 3, pp 509-517, issn 0008-543X, 9 p.Article

Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassayRAPPU, Pekka; NYLUND, Camilla; PYRHÖNEN, Seppo et al.International journal of cancer (Print). 2011, Vol 128, Num 10, pp 2382-2392, issn 0020-7136, 11 p.Article

Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancersLACOMBE, Jérôme; MANGE, Alain; JARLIER, Marta et al.International journal of cancer (Print). 2013, Vol 132, Num 5, pp 1105-1113, issn 0020-7136, 9 p.Article

Circulating thymus-and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injuryMIYAZAKI, Eishi; NUREKI, Shin-Ichi; ONO, Emiko et al.Chest. 2007, Vol 131, Num 6, pp 1726-1734, issn 0012-3692, 9 p.Article

Serum Mac-2BP Does Not Distinguish Men With High Grade, LargeVolume Prostate Cancer From Men With Benign Prostatic HyperplasiaPEEHL, Donna M; ZUXIONG CHEN; NOLLEY, Rosalie et al.The Prostate. 2011, Vol 71, Num 1, pp 26-31, issn 0270-4137, 6 p.Article

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosisCHO, Wcs; YIP, T. T; CHENG, W. W et al.British journal of cancer. 2010, Vol 102, Num 12, pp 1731-1735, issn 0007-0920, 5 p.Article

Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancerKUEFER, R; HOFER, M. D; ZORN, C. S. M et al.British journal of cancer. 2005, Vol 92, Num 11, pp 2018-2023, issn 0007-0920, 6 p.Article

Development and validation of a standardized ELISA for the detection of soluble Fc-epsilon-RI in human serumLEXMOND, Willem; VAN DERMEE, John; RUITER, Floortje et al.Journal of immunological methods. 2011, Vol 373, Num 1-2, pp 192-199, issn 0022-1759, 8 p.Article

Development of a sandwich ELISA for the 5.9-kDa fibrinogen alpha C chain fragment detected by serum proteome analysisNODA, Kenta; SOGAWA, Kazuyuki; KIKUCHI, Wataru et al.Proteomics. Clinical applications (Print). 2011, Vol 5, Num 3-4, pp 141-146, issn 1862-8346, 6 p.Article

The Amelioration of AH by Abstinence and the Attenuation of Oxidative StressTIANYI WANG; DONG ZHU; XINPIN XU et al.Hepato-gastroenterology. 2012, Vol 59, Num 113, pp 73-76, issn 0172-6390, 4 p.Article

The Value of Serum Biomarkers in Prediction Models of Outcome After Mild Traumatic Brain InjuryTOPOLOVEC- VRANIC, Jane; POLLMANN-MUDRYJ, Mary-Ann; OUCHTERLONY, Donna et al.The Journal of trauma, injury, infection, and critical care. 2011, Vol 71, Num 5, issn 1079-6061, S478-S486, SUP1Article

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysisXUE, A; SCARLETT, C. J; CHUNG, L et al.British journal of cancer. 2010, Vol 103, Num 3, pp 391-400, issn 0007-0920, 10 p.Article

Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer modelVAFADAR-ISFAHANI, Baharak; LAVERSIN, Stephanie Anne-Sophie; AHMAD, Murrium et al.Proteomics. Clinical applications (Print). 2010, Vol 4, Num 8-9, pp 682-696, issn 1862-8346, 15 p.Article

Identification of Apolipoprotein Al as a serum biomarker of chronic kidney disease in liver transplant recipients, using proteomic techniquesO'RIORDAN, Aisling; JOHNSTON, Olwyn; RYAN, Michael P et al.Proteomics. Clinical applications (Print). 2008, Vol 2, Num 9, pp 1338-1348, issn 1862-8346, 11 p.Article

Investigation of serum proteome alterations in human glioblastoma multiformeGOLLAPALLI, Kishore; RAY, Sandipan; SRIVASTAVA, Rajneesh et al.Proteomics (Weinheim. Print). 2012, Vol 12, Num 14, pp 2378-2390, issn 1615-9853, 13 p.Article

Identification of potential serum markers for endometrial cancer using protein expression profilingTAKANO, Masashi; KIKUCHI, Yoshihiro; YAEGASHI, Nobuo et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 3, pp 475-481, issn 0171-5216, 7 p.Article

Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarker of phospholipidosis in ratsTHOMPSON, Karol L; JUN ZHANG; STEWART, Sharron et al.Toxicology letters. 2012, Vol 213, Num 2, pp 285-291, issn 0378-4274, 7 p.Article

Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/lonization-based decision tree classificationYUN YU; SHENG CHEN; CHEN, Guo-Qiang et al.Oncology. 2005, Vol 68, Num 1, pp 79-86, issn 0030-2414, 8 p.Article

Doxycycline Effects on Serum Bone Biomarkers in Postmenopausal WomenGOLUB, L. M; LEE, H.-M; STONER, J. A et al.Journal of dental research. 2010, Vol 89, Num 6, pp 644-649, issn 0022-0345, 6 p.Article

Oxidation of specific methionine and tryptophan residues of apolipoprotein A-I in hepatocarcinogenesisFERNANDEZ-IRIGOYEN, Jokin; SANTAMARIA, Enrique; CORRALES, Fernando J et al.Proteomics (Weinheim. Print). 2005, Vol 5, Num 18, pp 4964-4972, issn 1615-9853, 9 p.Article

Current status of prognostication in classical Hodgkin lymphomaVENKATARAMAN, Girish; KAMRAN MIRZA, M; EICHENAUER, Dennis A et al.British journal of haematology. 2014, Vol 165, Num 3, pp 287-299, issn 0007-1048, 13 p.Article

Biomarker discovery using a comparative omics approach in a mouse model developing heterogeneous mammary cancer subtypes : Cancer ProteomicsPENNINGS, Jeroen L. A; VAN DYCKE, Kirsten C. G; OOSTROM, Conny T. M. Van et al.Proteomics (Weinheim. Print). 2012, Vol 12, Num 13, pp 2149-2157, issn 1615-9853, 9 p.Conference Paper

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overviewBÜNGER, S; LAUBERT, T; ROBLICK, U. J et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 3, pp 375-389, issn 0171-5216, 15 p.Article

Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studiesAMACHER, David E.Toxicology (Amsterdam). 2011, Vol 279, Num 1-3, pp 10-18, issn 0300-483X, 9 p.Article